Jack Nathan Medical Corp. (V:JNH*CA)
Business Focus: Healthcare Facilities & Services (NEC)
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| Company Contact | |
| Address: | 6-6150 Highway 6,, Suite 491 WOODBRIDGE ON L4H 0R6 |
| Tel: | N/A |
| Website: | https://www.jacknathanhealth.com |
| IR: | See website |
| Key People | ||
| Glenn Copeland President, Chief Executive Officer, Chief Medical Officer, Director | Michael Marchelletta Executive Vice Chairman of the Board | Bharat Choudhary Chief Financial Officer | Marcy Herriman Chief Operating Officer |
| Business Overview |
| Jack Nathan Medical Corp. is a Canada-based omni-channel healthcare company. The Company is a provider of primary care medical clinics located in Walmart Supercenters under the Jack Nathan Health brand. It provides its medical services throughout Canada and Mexico. JNH has a diversified network of medical practitioners, and through its alliance with Walmart, it provides medical services through JNH Medical Clinics located inside Walmart Supercenters. It offers patient care through patient-centric physician, a variety of medical services, technology, and programs. Through JNH Medical Clinics, it offers family practice, walk-in and urgent care services, specialist health care services, dental, telemedicine and virtual nurse care, and more. It also provides health and wellness treatments through JNH Med Spa, and injury and health support programs through JNH Rehab. It operates over 77 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec. |
| Financial Overview |
| For the nine months ended 31 October 2023, Jack Nathan Medical Corp revenues increased 16% to C$13.7M. Net loss increased 26% to C$4.4M. Revenues reflect Mexico segment increase of 61% to C$4.1M, Canada segment increase of 4% to C$9.7M. Higher net loss reflects Acquistion related costs increase from C$248K to C$1.1M (expense), Clinic supplies increase from C$256K to C$955K (expense). |
| Employees: | 24 as of Apr 30, 2020 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $7.88M as of Oct 31, 2023 |
| Annual revenue (TTM): | $17.42M as of Oct 31, 2023 |
| EBITDA (TTM): | -$3.68M as of Oct 31, 2023 |
| Net annual income (TTM): | -$7.80M as of Oct 31, 2023 |
| Free cash flow (TTM): | -$8.92M as of Oct 31, 2023 |
| Net Debt Last Fiscal Year: | $6.32M as of Oct 31, 2023 |
| Shares outstanding: | 87,099,159 as of Nov 8, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.